Skip to main content

Advertisement

SpringerLink
Log in

Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine

  • Feature Article
  • Published:
Chinese Journal of Integrative Medicine Aims and scope Submit manuscript

Abstract

Microcirculation of liver cancer is the micro-vascular system which comes from the tissue of liver cancer. It can offer the nutritional requirement for accelerating the cancer cell proliferation and metastasis. The intrinsic mechanism of angiogenesis is the key link in the formation of liver cancer microcirculation system. Liver regeneration microenvironment also plays an important role in the construction of liver cancer microcirculation, through the improvement of liver regeneration microenvironment affecting tumor microcirculation is the new strategy of prevention and treatment of liver cancer. In recent years, it is found that many kinds of Chinese medicine can inhibit angiogenesis, decrease the microvessel density, and delay or prevent the development of liver cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Xu CY, Ni QG, Zhang LY. Tumor microenvironment and tumor angiogenesis. China Healthcare Frontiers 2009;4:2123,90.

    Google Scholar 

  2. Folkmanm J. Fundamental concepts of the angiogenic process. Curr Mol Med 2003;3:643–651.

    Article  Google Scholar 

  3. Zhang YL, Zhou SJ, Li SW. The function of VEGF and Notch pathway in the formation of liver cancer angiogenesis. Progress Physiol Sci (Chin) 2014;45:205–208.

    CAS  Google Scholar 

  4. Li HM, Zhao BB, Gao X, Shen X, Wu Y, Zhang JR, et al. Tonifying Kidney network to modulate liver regeneration microenvironment to prevent and cure liver cancer. J Hubei Univ Tradit Chin Med (Chin) 2015;17:5–8.

    Google Scholar 

  5. Li H, Ye Q, Yin XJ, Li YM. Research progress of angiogenesis in hepatocellular carcinoma. Chin Clinic Oncol 2009;14:369–372.

    Google Scholar 

  6. Hei ZY, Wang L, Jin HM. Research progress of relationship between VEGF and angiogenesis in primary liver cancer. J Chin Microcircul (Chin) 2005;9:292–294.

    Google Scholar 

  7. Scaveni C, Vacca A, Di Pietro G, Dammacco F, Ribatti D. Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia 2004;18:1054–1058.

    Article  Google Scholar 

  8. Coussens LM, Fingleton B, Matrisian LM. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 2002;295:2387–2392.

    Article  CAS  PubMed  Google Scholar 

  9. Otrock ZK, Mahfouz RA, Makarem JA, Shamseddine AI. Understanding the biology of angiogenesis: review of the most important molecular mechanisms. Blood Cells Mol Dis 2007;39:212–220.

    Article  CAS  PubMed  Google Scholar 

  10. Ding T, Xu J, Zhang Y, Guo RP, Wu WC, Zhang SD, et al. Endothelium-coated tumor clusters are associated with poor prognosis and micrometastasis of hepatocellular carcinoma after resection. Cancer 2011;117:4878–4889.

    Article  PubMed  Google Scholar 

  11. Zhong C, Wei W, Su XK, Li HD, Xu FB, Guo RP. Serum and tissue vascular endothelial growth factor predicts prognosis in hepatocellular carcinoma patients after partial liver resection. Hepatogastroenterology 2012;59:93–97.

    CAS  PubMed  Google Scholar 

  12. Shi JH, Liu SZ, Wierød L, Scholz H, Anmarkrud JA, Huitfeldt HS, et al. RAF-targeted therapy for hepatocellular carcinoma in the regenerating liver. J Surg Oncol 2013;107:393–401.

    Article  CAS  PubMed  Google Scholar 

  13. Cao GW, Wang B. Interventional nursing. Beijing: People's Medical Publishing House; 2005:7173–7174.

    Google Scholar 

  14. Li HM. Construction and application of tertiary prevention program for liver cancer based on "tonifying the Kidney to promote liver regeneration and repair by affecting stem cells and their microenvironment". Chin J Integr Tradit West Med Liver Dis (Chin) 2015;25:369–372.

    Google Scholar 

  15. Li HM. Regulation of liver regeneration:Research progress and prospect. World Chin J Digestol 2015;23:3337–3343.

    Article  CAS  Google Scholar 

  16. Sheng QS, Wang W. Research progress for the effect of preventing liver cancer angiogenesis by using traditional Chinese medicine. Chin J Integr Tradit West Med Liver Dis 2014;24:61–64.

    CAS  Google Scholar 

  17. Li PC, Wei AL, Zhang YQ, Tang QY. Research status on traditional Chinese medicine of angiogenesis in hepatocellular carcinoma. Popul Sci Technol (Chin) 2014;16:136–138.

    CAS  Google Scholar 

  18. Zhang B, Huang GX, Zhang YQ, Chen XX, Hu PL, Xu BP. Clinical observation on prevention of "Jia Wei Si Jun Zi Tang" from damage of hepatic reserving function after intervention of liver cancer. J Chin Med Mater 2004;27:387–389.

    Google Scholar 

  19. Cui YF, Zu MH, Xu H, Gu YM, Li GJ, Zhang QQ, et al. Severe complications after transcatheter arterial chemoembolization for hepatocellular carcinoma. Chin J Interv Imag Therapy 2005;2:31–33.

    Google Scholar 

  20. Huang G, Wang YQ, Tan MD, Xie HH, Li W, Liu GW. The research progress of curcumin antitumor mechanism. Anti- Tumor Pharm (Chin) 2014;4:328–331.

    Google Scholar 

  21. Li HM, Yan XS, Ming AP, Peng YQ. The effect of liposomecurcumin on inhibitory Bel-7402 cell proliferation and induction apoptosis. Chin J Integr Tradit West Med Liver Dis (Chin) 2005;15:214–217.

    Google Scholar 

  22. Li HM, Yan XS, Ming AP, Peng YQ, Gui WJ. Stability of anti-liver cancer efficacy by liposome-curcumin in water solution. Chin Tradit Herb Drugs (Chin) 2006;37:561–565.

    CAS  Google Scholar 

  23. Ni Q, Zeng SE, Tan N, Guo F, Zhang MY. Effect of curcumin on the proliferation and apoptosis of hepatocellular carcinoma Hepl cells. Shandong Med J (Chin) 2010;50:6–8.

    CAS  Google Scholar 

  24. Zhao BB, Li HM, Gao X, Ye ZH, Cheng SS. The herbal compound "Diwu Yanggan" modulates liver regeneration by affecting the hepatic stem cell microenvironment in 2-acetylaminofluorene/partial hepatectomy rats. Evid Based Complement Alternat Med 2015:468303.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Liver Diseases of Hubei Provincial Hospital of Traditional Chinese Medicine, National Scientific Research Level-3 Laboratory of Cell and Molecular Biology of Traditional Chinese Medicine, Key Research Office of the State Administration of Traditional Chinese Medicine on the Treatment of Chronic Liver Diseases on the Dialectical Thought of Liver and Kidney, Wuhan, China

    Han-min Li  (李瀚旻)

Authors
  1. Han-min Li  (李瀚旻)
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Hm. Microcirculation of liver cancer, microenvironment of liver regeneration, and the strategy of Chinese medicine. Chin. J. Integr. Med. 22, 163–167 (2016). https://doi.org/10.1007/s11655-016-2460-y

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11655-016-2460-y

Keywords

Search

Navigation